We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
195 own
19 watching
Current Price
$10.9
$-0.03
(-0.27%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
13,217.92M
52-Week High
15.6
52-Week Low
8.42
Average Volume
5.55M
Dividend Yield
0.016023
P/E Ratio
--
Market Capitalization13,217.92M
52-Week High15.6
52-Week Low8.42
Average Volume5.55M
Dividend Yield0.016023
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions and leverage their collective expertise to connect more people to more products and services through their one-of-a-kind Global Healthcare Gateway™. Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
PR Newswire
8days ago
Viatris Completes Biosimilars Transaction with Biocon Biologics Viatris Completes Biosimilars Transaction with Biocon Biologics PR Newswire PITTSBURGH, Nov. 29, 2022 Receives a $2 BillionCash Payment and$1 Billionof Convertible Preferred Equity Representing a Stake of at Least 12.9% (on a Fully...
PR Newswire
9days ago
Thinking about buying stock in Lululemon Athletica, Digital Brands, COMSovereign, Viatris, or Exxon Mobil? Thinking about buying stock in Lululemon Athletica, Digital Brands, COMSovereign, Viatris, or Exxon Mobil? PR Newswire NEW YORK, Nov. 28, 2022 NEW YORK, Nov. 28, 2022 /PRNewswire...
PR Newswire
19days ago
Viatris Named U.S. In-House Legal Team of the Year for Intellectual Property Litigation by LMG Life Sciences Viatris Named U.S. In-House Legal Team of the Year for Intellectual Property Litigation by LMG Life Sciences PR Newswire PITTSBURGH, Nov. 18, 2022 PITTSBURGH, Nov. 18, 2022 /PRNewswire...
PR Newswire
21days ago
Thinking about buying stock in Carnival Corp, Viatris, Micron Technology, Tencent Music Entertainment, or Bilibili? Thinking about buying stock in Carnival Corp, Viatris, Micron Technology, Tencent Music Entertainment, or Bilibili? PR Newswire NEW YORK, Nov. 16, 2022 NEW YORK, Nov. 16, 2022...
PR Newswire
27days ago
Viatris Wins Court Decision Invalidating AstraZeneca's Symbicort Patent Viatris Wins Court Decision Invalidating AstraZeneca's Symbicort Patent PR Newswire PITTSBURGH, Nov. 10, 2022 PITTSBURGH, Nov.10, 2022 /PRNewswire/ -- Viatris Inc.(NASDAQ: VTRS), a global healthcare company, today announced...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$10.9
$-0.03
(-0.27%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00